Ureteroscopy and laser lithotripsy

 Ureteroscopy and laser lithotripsy is a safe and effective operation to treat kidney stones. This is a minimally- invasive procedure where kidney stones are destroyed with a special laser, without the need for any incisions. Compared to extracorporeal shockwave lithotripsy (the destruction of stones with sound waves), ureteroscopy and laser lithotripsy is more effective with a lower need for repeat treatments.
You may continue your normal medications prior to surgery. You do NOT need to stop any of your medications that affect bleeding including ASA (Aspirin), ibuprofen (Advil), warfarin (Coumadin), clopidogrel (Plavix), ticagrelor (Brilinta), other non-steroidal anti-inflammatories (NSAIDs), dabigatran (Pradaxa), rivaroxaban (Xarelto) and apixaban (Eliquis). If you have any questions about your medications prior to surgery, please contact your surgeon. Do not eat or drink anything after midnight the night before your surgery. You may eat your normal diet up until
The operation Ureteroscopy and laser lithotripsy is performed under a general anesthetic, meaning you will be asleep for the operation. The operation is performed using small telescopes through the urethra (the tube that allows flow of urine from the bladder). Your stone will be destroyed using a special laser. Once the stone has been destroyed, a ureteral stent (a temporary plastic tube that runs from the kidney down to the bladder) will be inserted. The operation Potential risks and complications Although the operation is very safe, a number of potential risks exist. These include the following: -­‐ Bleeding -­‐ Infection -­‐ Inability to treat the stone, requiring additional treatments in the future -­‐ Incomplete treatment of the stone, requiring additional treatments in the future -­‐ Injury to the ureter (the tube that drains urine from the kidney to the bladder) -­‐ Scarring of the ureter, requiring additional treatments in the future to treat the scar -­‐ General risks associated with all types of surgery including heart attack, stroke and blood clots in the legs or
-­‐ Length of hospitalization: You can return home the day of your surgery. -­‐ Pain: You may experience some mild discomfort after surgery in the kidney and/or in the bladder. This can be treated with pain medications by mouth. -­‐ Diet: You will be able to resume your normal diet after your surgery. -­‐ Ambulation: You are encouraged to walk around beginning in the evening after your surgery. -­‐ Pain: You may experience some discomfort in kidney and/or bladder after your discharge. This can usually be controlled with Extra-Strength Tylenol. You will be given a prescription for a stronger pain medication in case it is needed. -­‐ Showering: You may shower or take a bath the day of your surgery. -­‐ Activity: Walking is strongly encouraged after your surgery. Prolonged lying in bed should be avoided to prevent the development of blood clots in your legs. You do NOT have to avoid heavy lifting, sports, vigorous activity or sexual activity; however, these activities may cause some discomfort. -­‐ Diet: You may resume your normal diet once you have returned home from hospital. -­‐ Work: Most people can return to work 2-3 days after surgery if they perform desk work or jobs with minimal physical activity. If your work requires heavy lifting or strenuous activity, you may have mild discomfort with work while the stent is inside your body. -­‐ Antibiotics: You may be given a prescription for antibiotics to take after your surgery to prevent infection. -­‐ Stent symptoms: Some patients do not feel the stent when it is inside their body though most are aware of some changes. Some patients experience bladder discomfort, pain with urination, increased frequency and urgency of urination, a small amount of blood in the urine and discomfort in the kidney. You may be prescribed a medication to help manage these symptoms called tamsulosin (Flomax), alfuzosin (Xatral), oxybutynin (Ditropan), tolterodine (Detrol) or solifenacin (Vesicare). -­‐ Stent removal: Your stent may have been left attached to a string, which will be taped or secured to the outside of your body. Your surgeon will remove the stent by pulling on this string 5-10 days after your surgery. You may be asked to remove your stent on your own by pulling on this string. If your stent does not have a string, it must be removed in an outpatient clinic by cystoscopy (insertion of a small telescope into the bladder.) This will typically be done 2-4 weeks after your surgery. -­‐ Follow-up appointment: You will need an appointment to visit your surgeon to have your stent removed. Please call your surgeon to schedule this appointment if it has not been done for you before your discharge  
Contact your surgeon if you experience any of the following after surgery: -­‐ Pain that is not controlled by your prescribed medications -­‐ Unexplained fever over 38.5 degrees Celsius/101 degrees Fahrenheit -­‐ Continuous leakage of urine (urinary incontinence) Proceed immediately to the emergency room if you experience any of the following after surgery: -­‐ Difficulty breathing or shortness of breath -­‐ You have a serious concern and are unable to contact your surgeon

Source: http://www.scarboroughurology.com/resources/Peri-operative-instructions/URETEROSCOPY-AND-LASER-LITHOTRIPSY.pdf

Microsoft word - vendor options.doc

Healthy Beverage and Snack Options for Vending Machines: As a merchant who decides what is loaded in a vending machine, consider including healthy alternatives to your already existing selection. Vending machine users like to make healthy selections in this health conscious environment. You may decide to stock at least 50% of items offered that are healthy choices, dedicate certain machines


Clin Oral InvestDOI 10.1007/s00784-005-0024-1Stefan-Ioan Stratul . Frank Schwarz . Jürgen Becker . Britta Willershausen . Anton SculeanHealing of intrabony defects following treatment with an oilycalcium hydroxide suspension (Osteoinductal). A controlledclinical studyReceived: 21 July 2005 / Accepted: 25 November 2005Abstract The purpose of the present clinical study was toCAL gains (P<0.

Copyright © 2018 Medical Abstracts